AIDS Clinical Trial Group / Bayer HealthCare AG / /
Continent
Asia / Africa / /
Country
Tanzania / Thailand / Kenya / China / Mexico / Zambia / South Africa / India / /
Event
FDA Phase / /
Facility
University College London / University of St. Andrews / /
IndustryTerm
treatment products / /
MedicalCondition
TB / drugsensitive tuberculosis / disease / AIDS / /
Organization
TB Alliance / National Institute of Health / Centre for Clinical Microbiology / University of St. Andrews / University College London / Medical Research Council Clinical Trials Unit / /
REMoxTB: Blazing a trail for future trials Shorter and simpler TB cures are urgently needed. REMoxTB was a Phase 3 clinical trial that tested whether substituting moxifloxacin for one of the existing first-line TB drugs